Inogen, Inc. (INGN)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Inogen, Inc. (INGN) is down 2.7% since the beginning of the year. At $7 per share, INGN is trading 28.4% below its 52-week high of $9. Investors who bought $1,000 worth of INGN shares 5 years ago would now be looking at an investment worth $97.

Inogen, Inc. (INGN) has returned -2.68% so far this year and -1.95% over the past 12 months. Over the last ten years, INGN has returned -17.76% per year, falling short of the S&P 500 Index benchmark, which averaged 13.71% annually.

Based on dividend-adjusted daily data since Feb 14, 2014, INGN's average daily return is +0.03%, while the average monthly return is +0.64%. At this rate, an investment would double in approximately 9.1 years.

Historically, 52% of months were positive and 48% were negative. The best month was Nov 2019 with a return of +35.2%, while the worst month was Jan 2020 at -35.2%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 6 months.

On a daily basis, INGN closed higher 51% of trading days. The best single day was Aug 7, 2024 with a return of +36.0%, while the worst single day was Feb 28, 2024 at -32.7%.

Inogen, Inc. has an annualized alpha of -4.14%, beta of 0.96, and R2 of 0.09 versus S&P 500 Index. Calculated based on daily prices since February 14, 2014.

• This stock participated in 171.02% of S&P 500 Index downside but only 90.20% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.09 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

INGN ranks 40 for risk / return — below 40% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Inogen, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Inogen, Inc. was 98.51%, occurring on Oct 27, 2023. The portfolio has not yet recovered.

The current Inogen, Inc. drawdown is 97.69%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Inogen, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Inogen, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.